Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $6 | $8 | $21 |
| Short-Term Investments | $90 | $102 | $116 | $120 |
| Receivables | $1 | $1 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $1 |
| Total Curr. Assets | $96 | $111 | $128 | $144 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $32 | $32 | $32 | $32 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $34 | $34 | $34 | $34 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $130 | $145 | $161 | $177 |
| Liabilities | – | – | – | – |
| Payables | $5 | $6 | $3 | $6 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $2 | $1 | $2 |
| Total Curr. Liab. | $14 | $14 | $9 | $12 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $2 | $2 | $2 |
| Other NC Liab. | $78 | $23 | $35 | $45 |
| Total NC Liab. | $80 | $25 | $38 | $48 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $94 | $39 | $47 | $59 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $56 | $0 | $56 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$391 | -$373 | -$362 | -$356 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $35 | $106 | $115 | $118 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $130 | $145 | $161 | $177 |
| Net Debt | -$4 | -$6 | -$8 | -$21 |